Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis.

Elizabeth Harlan MichelleIago Pinal-FernandezMaria Casal-DominguezJemima AlbaydaJulie J PaikEleni TiniakouBrittany AdlerChristopher A MecoliSonye K DanoffLisa Christopher-StineAndrew L MammenThomas E Lloyd

Published in: Neurology (2023)

Our study demonstrates that female and Black patients have distinct clinical phenotypes and trajectories within the overarching IBM clinical phenotype. These subgroups may have different responses to therapies which may influence the design of future clinical trials in IBM.

Keyphrases

clinical trial
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
randomized controlled trial
rheumatoid arthritis
prognostic factors
peritoneal dialysis
open label
idiopathic pulmonary fibrosis
phase ii
patient reported
placebo controlled